India’s Bharat Biotech has signed an agreement with a medicine distributor to supply its COVID-19 vaccine to Brazil, it said on Tuesday, even as the shot’s emergency use approval in its home country has faced criticism.
For more coronavirus news, visit our dedicated page.
India’s drug regulator has given emergency use approval to Bharat Biotech’s COVAXIN, as well as to AstraZeneca and Oxford University’s Covishield vaccine, which is being produced by the Serum Institute of India.
For all the latest headlines follow our Google News channel online or via the app
But health experts and opposition lawmakers have criticized approval of COVAXIN due to a lack of efficacy data, which the manufacturer is still conducting.
Bharat Biotech said it has signed an agreement with a Brazil-based pharmaceutical seller, Precisa Medicamentos, to supply COVAXIN.
“It is understood between both parties that supplies of COVAXIN (are) to be prioritized for the public market, through a direct procurement by the government of Brazil,” the Indian company said in a statement.
Coronavirus: Should I get a COVID-19 vaccine if I’ve had the virus?
Criticism of India’s approval of the vaccine has grown after news that a regulatory panel approved the shot just one day after asking the vaccine maker for more evidence it would work.
Bharat Biotech, which developed COVAXIN with the Indian Council of Medical Research (ICMR), said supplies to the private market would depend on authorization from the Brazilian regulatory authority.
Brazil has registered over 8 million cases of the virus since the pandemic began, while the official death toll has risen over 203,000, the world’s second-deadliest coronavirus outbreak.
Brazil has signed agreements to receive other COVID-19 vaccines. Authorities there are facing growing pressure to speed up the vaccine rollout, which is lagging regional peers. Mexico, Chile and Argentina have already begun immunizations.
Coronavirus: Brazil researchers report modest 50.4 pct efficacy for China’s CoronaVacA coronavirus vaccine developed by China’s Sinovac showed “general efficacy” of 50.4 percent in a late-stage trial in Brazil, the company’s local ... Coronavirus
Should I get a COVID-19 vaccine if I’ve had the virus?Should I get a COVID-19 vaccine if I’ve had the virus?Yes. Regardless of previous infection, the US Centers for Disease Control and Prevention says ... Coronavirus
Coronavirus: Ukraine asks EU for more help getting COVID-19 vaccinesUkrainian President Volodymyr Zelenskiy on Tuesday asked European Union countries for more help in procuring coronavirus vaccines after his government ... Coronavirus
India to decide on coronavirus vaccine exports in few weeks, says foreign ministerIndia will be able to decide on exports of coronavirus vaccines within the next few weeks, Foreign Minister Subrahmanyam Jaishankar said on Tuesday, ... World News
Coronavirus: Get poorest children back to school for $370, a charity urgesSave the Children on Tuesday called for urgent action to help kids in the world’s poorest countries to return to schools closed as part of coronavirus ... Coronavirus
Coronavirus: India prepares for ‘world’s biggest vaccination drive'Indian airlines started delivering batches of COVID-19 vaccines across the country on Tuesday, getting ready for the launch of a campaign to offer ... Coronavirus